ing their performance through enzyme engineering, producing enzyme components such as recombinant hydrogenase enzymes to replace costly platinum or other catalysts in fuel cells, and making arrays of such enzymes on a large scale via fermentations.
Producing Hydrogen via Cell-free Synthetic Pathway Biotransformations
Cell-free synthetic pathway biotransformation (SyPaB) entails assembling arrays of different enzymes to produce specific end products without side pathways or cell replication. It is a new direction for synthetic biology,
Summary
• With transportation accounting for about 20% of global energy use, future transportation systems need to shift to hydrogen for making electricity because they can be produced from diverse and renewable resources.
• Synthetic enzymatic pathway biotransformation (SyPaB) assembles sets of stable enzymes and coenzymes to produce hydrogen or other valuable end products efficiently and without cell mass or other by-products.
• SyPaB systems now can produce 12 molecules of hydrogen from one molecule of glucose equivalent of polysaccharides.
which applies engineering principles to design novel systems that perform better than their natural counterparts. The design principles of cell-free synthetic biology enable us to assemble a new system much more easily than it would be to modify a living system. Specifically, it frees us from the restraints of dealing with cellular viability, physiology, regulation, and the presence of membranes and cell walls.
The development cycle of SyPaB involves five stages with expert input from many specialists: (i) pathway reconstruction, (ii) enzyme selection, (iii) enzyme engineering, (iv) enzyme production and purification, and (v) process engineering. However, constructing cell-free synthetic enzymatic pathways, which typically are based on natural metabolic pathways, is the central focus of SyPaB. The pathways are designed to account for ATP and NAD(P) balances, thermodynamics, reaction equilibria, product separations, and overall production efficiencies. Enzyme selection is particularly critical, with stability dictating a reliance on extremophile microorganisms as a key resource. Enzymes can be engineered to enhance properties such as catalytic efficiency selectivity and cofactor preference by procedures such as rational design and directed evolution.
A SyPaB approach to producing hydrogen efficiently from abundant biomass could reach nearly zero net carbon emissions. One such approach entails building a synthetic enzymatic pathway to generate 12 molecules of hydrogen per single glucose equivalent of polysaccharides and water (Fig. 1) . It differs from the natural hydrogen-production pathway, which has a theoretical yield of four molecules of hydrogen per glucose molecule.
To achieve such high yields, this synthetic system incorporates several modules based on natural metabolic processes, a combination of which does not exit together in nature. For instance, it contains a carbohydrate polymer chain-shortening reaction that depends on phosphorylase to produce glucose-1-phosphate (G-1-P), which is converted to glucose-6-phosphate (G-6-P) via phosphoglucomutase (Eq. 1 and 2). This system also includes the 10 enzymes of the pentose phosphate pathway to yield 12 NADPH equivalents per molecule of G-6-P (Eq. 3). They are used to generate hydrogen via hydrogenase (Eq. 4).
(C 6 H 10 O 5 ) n ϩ H 2 OϩP i 7 (C 6 H 10 O 5 ) nϪ1
F I G U R E 1
The synthetic pathway for converting glucan and water to hydrogen and carbon dioxide. PPP, pentose phosphate pathway. The enzymes are: GNP, glucan phosphorylase; PGM, phosphoglucomutase; G6PDH, G-6-P dehydrogenase; 6PGDH, 6-phosphogluconate dehydrogenase; R5PI, phosphoribose isomerase; Ru5PE, ribulose 5-phosphate epimerase; TKL, transketolase; TAL, transaldolase; TIM, triose phosphate isomerase; ALD, aldolase; FBP, fructose-1, 6-bisphosphatase; PGI, phosphoglucose isomerase; and H2ase, hydrogenase. The metabolites and chemicals are: g1p, glucose-1-phosphate; g6p, glucose-6-phosphate; 6pg, 6-phosphogluconate; ru5p, ribulose-5-phosphate; x5p, xylulose-5-phosphate; r5p, ribose-5-phosphate; s7p, sedoheptulose-7-phosphate; g3p, glyceraldehyde-3-phosphate; e4p, erythrose-4-phosphate; dhap, dihydroxacetone phosphate; fdp, fructose-1,6-diphosphate; f6p, fructose-6-phosphate; and P i , inorganic phosphate. 
In sum:
3 12H 2 (gas) ϩ 6CO 2 (gas) (5) This overall reaction (Eq. 5) is spontaneous (⌬G o ϭ Ϫ48.9 kJ/mol) and endothermic (⌬H o ϭ 596 kJ/mol), according to thermodynamic analysis. These reactions produce more energy output in the form of hydrogen than energy input in the form of carbohydrate (e.g., 22% gain in combustion enthalpy).
During the past several years, we have increased the rates of these reactions nearly 20-fold by optimizing enzyme loadings, increasing substrate concentrations, and elevating the reaction temperature to 32 o C. To further increase rates and improve the stability of the process, we are cloning, purifying, characterizing, and analyzing thermostable enzymes for their possible use in this system.
Several Advantages in Following the SyPaB Approach
SyPaB offers an approach for combining complicated sets of biochemical reactions in ways that working with microbes or single enzymes do not. In theory, this approach provides a means for generating useful products such as hydrogen in high yields. This cell-free approach also circumvents energy losses from processes in living microorganisms that meet their vital needs such as metabolism, cell maintenance, and replication. A living microorganism contains thousand of different proteins, whereas a SyPaB system is designed to contain only those enzymes that are needed for making specific products.
To be cost effective, any industrial process depends on balancing three key factors-product yield, titer, and productivity. To make biofuels from renewable carbohydrates, product yield is the most important cost factor. Raw carbohydrates cost about $0.18 per kg or $10.6
per GJ, whereas a typical biofuel ethanol costs $22.1 per GJ at $2 per gallon, requiring ethanol yield to be at least 70 -80%, excluding subsidies. Analyses for other biofuels such as butanol, microdiesel, and hydrocarbons suggest roughly similar product yields. However, natural hydrogen fermentations produce only 4 molecules of hydrogen per glucose unit, making this approach for generating hydrogen from carbohydrates economically prohibitive, except in situations where it is used to treat wastewater (free carbohydrate). SyPaB provides a means for producing nearly 12 moles of hydrogen per mole of glucose in biomass. Beyond raising product yields, SyPaB provides a ready means for assembling enzymatic pathways in vitro, while avoiding the complexities of living cells such as their requirements for meeting physiological requirements and maintaining DNA, protein assembly machinery, membranes, and walls. Moreover, with SyPaB there are no cell
F I G U R E 2
Comparison of weight-based total turnover number (TTN W ). * denotes immobilized enzymes. Phosphoglucomutase from C. thermocellum, 6-phosphogluconate dehydrogenase from T. maritima, and fructose-1,6-bisphosphatase from T. maritima. membranes or walls to slow substrate and product transport and to waste energy in doing so. It also becomes possible to raise the concentrations of relevant enzymes by eliminating other cellular proteins and biomacromolecules.
Biocatalyst Cost Comparison
At first glance, microbial fermentations look cheaper and simpler than SyPaB because microbes are replenished via self-replication, whereas enzymes are not. However, further analysis provides another look at these cost issues. This analysis depends on a new termweight-based total turnover number (TTN W ) in terms of the kg of product per kg of biocatalyst being used: Meanwhile, the use of pure enzymes leads to higher TTN W values, ranging from 50 to more than 1,000,000. Values with free enzymes typically are more than two orders of magnitude lower than those with immobilized enzymes because the latter can be stabilized and recycled. Enzymatic hydrolysis of pretreated cellulosic biomass, for example, leads to TTN W values ranging from 50 to 100, whereas starch hydrolysis requires far lower amounts of amylase and glucoamylase, resulting in a TTN W of about 500 to 1,000. It is one of the reasons that it is cheaper to make ethanol from corn kernels than from lignocellulosic biomass. Recently, we identified two recombinant thermostable enzymes as building blocks of a particular SyPaB, both of which have TTN W values of about 400,000. The two enzymes withstand 60 o C or higher temperatures, and derive from a thermophile, Clostridium thermocellum, and from a hyperthermophile, Thermotoga martima.
Although any SyPaB would include a number of stabilized enzymes, having TTN W values that are several orders of magnitude higher than those for microbes could lead to lower biocatalyst costs. For example, the costs for enzymes in SyPaB are on the same level as those for microbes based on the following assumptions: TTN W values of 20 and 20,000 for microbe and enzymes, respectively; recombinant protein yields of 0.1 g/g of cell mass; and costs for enzyme purification and stabilization that are 20-fold higher than those for the crude protein.
In addition to much higher TTN W values, the SyPaB system benefits from not synthesizing macromolecules or side-products.
F I G U R E 3
Scenarios of the carbohydrate-to-hydrogen or electricity by using combination of plants as natural solar cells, biomass sugars as hydrogen carriers, and SyPaB reforming. SyPaB has great potential for further reducing enzyme costs. For example, immobilizing thermophilic enzymes may raise TTN W values to 1,000,000 or higher, the same level as for industrial glucose isomerase. Further, high-cell density fermentations on an industrial scale might reduce recombinant thermophilic enzyme production costs. Moreover, heat precipitation steps provide a simple way for purifying some thermostable recombinant proteins produced in mesophilic hosts. Some industrial enzymes now cost as little as $40 per kg of dry enzyme. Therefore, development of low-cost stable enzymes is one of the top research topics for in vitro synthetic biology projects. Extremophilic microorganisms are a good source for such enzymes.
Replenishing Cofactors Poses Another Challenge
In addition to enzymes, stable and cheap cofactors are also needed for SyPaB systems to function efficiently. For instance, NAD(P) is costly and must be regenerated. The costs of such cofactors were once universally considered too high to permit their use in industrial-scale production. Recently, however, pharmaceutical companies began using them to produce highvalue chiral compounds. For example, NAD linked with polyethelene glycol can be regenerated through more than 80,000 cycles to produce L-leucineand more than 600,000 times for Lphenylalanine. NAD turnover cycles go even higher, to more than 1,000,000 for particular chemical syntheses.
Another promising approach entails replacing NAD(P) with more stable and low-cost analogues. For instance, triazine is the basis for a range of biomimetic analogues of NAD(P)H, according to Christopher Lowe and collaborators at the University of Cambridge in the United Kingdom. These low-cost redox molecules substitute for coenzymes, for example, in reactions involving alcohol dehydrogenase from horse liver, even though the analogues share little structural similarity with natural NAD(P). Similarly, Nbenzyl-1,4-dihydrononicotinamide and its derivatives also can substitute for NAD(P), according to Richard Fish at the Livermore Berkeley National Laboratory in California. Engineered cytochrome P450 can use these NAD(P) analogues efficiently. Further engineering of oxidoreductase enzymes is expected to increase their capacities and catalytic efficiencies when they are forced to use low-cost, stable biomimetic cofactors instead of their natural counterparts.
When the costs of stabilized enzymes and coenzyme are decreased as expected, the hydrogen production costs through SyPaB would be as low as $1.50 per kg of hydrogen based on the carbohydrate costs of $0.18 per kg of sugar. This hydrogen would be cheaper than that from from natural gas at $2.70 per kg of hydrogen.
F I G U R E 4
Comparison of the energy efficiency for different power train systems converting biomass to kinetic energy. ϭ 38%, biomass-to-electricity; 80%, battery recharging; 90%, motor; 60%, carbohydrate isolated from biomass; 95%, ethanol fermentation; 17%, internal combustion engine and transmission (ICE); 91%, ethanol-to-hydrogen autothermal reformation (ATR); 50%, fuel cell (FC); 90%, motor; carbohydrate-tohydrogen bioreforming, 122%.
Considering the benefits of using biomass and decreasing greenhouse gas emissions, SyPaB systems someday might provide a competitive means for generating hydrogen.
Prospects for SyPaB Systems
Biomass is our most abundant renewable bioresource, dependent on plants that transform solar energy into carbohydrates. Harnessing chemical energy from terrestrial plants is easier and less costly than doing so from algae. Terrestrial plants can be grown locally, harvested, stored, and distributed relatively easily compared to algae.
SyPaB systems face two major obstacles-a lack of stable enzymes and a cheap supply of coenzymes. Yet, interest from the pharmaceutical and related industries spurred efforts to discover and engineer thermostable enzymes with profitable applications from extremophiles, including DNA polymerase, amylase, glucose isomerase, hydrogenase, and cellulase. Similar ingenuity can be brought to solve challenges facing SyPaB, where different kinds of enzymes are needed to catalyze catabolic pathways for the purpose of harnessing biochemical energy. When a greater variety of stable enzymes and cofactor analogues becomes available, cell-free SyPaB could begin to compete with microbial fermentations in producing hydrogen or electricity (Fig. 3) .
Another important research challenge for SyPaB is to develop ways to increase reaction rates (productivity). The approaches would entail optimizing use of individual enzymes in metabolic pathways based on metabolic control and flux analysis, use of high substrate and enzyme concentrations, operating metabolic pathways at very high temperatures while using hyperthermophilic enzymes for catalysts, and even construction of metabolite challenging among the cascade enzymes. In our lab-scale, enzymedriven hydrogen production projects, we increased reaction rates nearly 20-fold, and we expect additional gains during the next years. Researchers in other labs are reporting huge, 1,000,000-fold increases in power densities, or reaction rates, in microbial fuel cells during the past 10 years.
A combination of bioreformer, polymer electrolyte membrane (PEM) fuel cells, and motor provides kinetic energy for wheels from sugars (Fig. 4a) . In terms of overall energy conversion efficiency from biomass to wheels (BTW), the carbohydrate-hydrogen-electricity-motor system appears to be the most energy efficient (Fig.  4b) . Its high efficiency is due to a net enthalpy gain of 122% from carbohydrate to hydrogen, where the low-temperature heat energy comes from the very high energy efficiency of PEM fuel cells (ϳ50%) and low energy loss in energy distribution.
